Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 ...

Research has found it is possible to temporarily reverse it by going on a strict, ultra-low calorie diet. However, this is ...

UNSW medical researchers say more Australians with type 2 diabetes need to be offered add-on medications that would better ...

More Australians with type 2 diabetes should gain access to potentially lifesaving medications, a new analysis has found.UNSW medical researchers say ...

Metabolize, a breakthrough solution to naturally address obesity, is excited to announce the publication of groundbreaking findings on their newly licensed metabolite, ...

A recent study from scientists at Northwestern University has revealed that two commonly prescribed drugs for treating type 2 ...

JOHANNESBURG, Sept 3 (Reuters) - Aspen Pharmacare (APNJ.J), opens new tab fell short of its targeted mid-single digit growth in core profit on Tuesday, but is betting on GLP-1 drug contracts to ...

The study also found no difference ... "Given increased interest in studying GLP-1 receptor agonists for the treatment of substance use disorders and other conditions, continued vigilance in ...

selling it in single-dose vials Study shows shift in GLP-1 drug use for obesity, not diabetes About 1% or fewer of the clinical trial participants reported suicidal thoughts or behaviors ...